14
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10718L |
CCT241533 hydrochloride
|
Chk | Cell Cycle/Checkpoint |
CCT241533 hydrochloride is an effective and selective ATP competitive inhibitor of CHK2 (Ki: 1.16 nM; IC50: 3 nM). | |||
T4428 |
CCT241736
|
FLT; Aurora Kinase | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors |
CCT241736 是一种口服生物可利用的双重 FLT3/Aurora 激酶抑制剂,还抑制临床相关的 FLT3 耐药突变体,包括 FLT3-ITD 和 FLT3。它是 CCT137690 的高级类似物,是治疗人类恶性肿瘤的临床前开发候选物。 | |||
T14905 |
CCT251236
|
HSP | Cytoskeletal Signaling; Metabolism |
CCT251236 is an orally available Pirin ligand obtained from a heat shock transcription factor 1 (hsf1) phenotypic screen. It inhibits HSF1-mediated HSP72 induction (IC50: 19 nM). | |||
T9638 |
CCT241161
|
Raf | MAPK |
CCT241161 is an orally active pan-RAF inhibitor, with IC50 values of 3, 6, 10, 15, and 30 nM for LCK, CRAF, SRC, V600E-BRAF, and BRAF, respectively. It displays significant activity against BRAF and NRAS mutant melanomas, as well as demonstrating anticancer cell proliferative effects [1]. | |||
T7080 |
CCT245737
SRA737 |
Chk | Cell Cycle/Checkpoint |
CCT245737 (SRA737) 是一种具有口服活性的选择性 Chk1 抑制剂,IC50值为 1.3 nM。 | |||
T14907 |
CCT251545
|
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
CCT251545 是一种有效的、具有口服活性的WNT 抑制剂,在 7dF3 细胞中对 WNT 抑制作用的IC50值为 5 nM。它是选择性化学探针,用于探索 CDK8 和 CDK19 在人类疾病中的作用。 | |||
T36704 |
CCT241533 dihydrochloride
CCT 241533 dihydrochloride |
||
Potent Chk2 inhibitor (IC50 = 3 nM). Shows >63-fold selectivity for Chk1 over Chk2 and a panel of 84 other kinases. Inhibits Chk2 activation in response to etoposide-induced DNA damage in HT29 cells. Blocks ionizing radiation-induced apoptosis of mouse thymocytes. Caldwell et al (2011) Structure-based design of potent and selective 2-(quinazolin-2-yl)phenol inhibitors of checkpoint kinase 2. J.Med.Chem. 54 580 PMID:21186793 | |||
T14906 |
CCT251455
|
Kinesin | Cytoskeletal Signaling |
CCT251455 is an inhibitor of mitotic kinase monopolar spindle 1 (MPS1; IC50: 3 nM). | |||
T71353 |
CCT239065
|
||
CCT239065 is a novel, selective, and efficacious nanomolar pyridopyrazinone V600EBRAF and LCK inhibitor. | |||
T22633 |
CCT251545 analogue, Compound 51
|
Others | Others |
CCT251545 analog is a potent and selective CDK8/19 inhibitor (IC50: 5.1 nM and 5.6 nM, respectively). Mediator complex-associated kinases CDK8 and CDK19 are involved in the regulation of multiple transcription pathways. CDK8 plays as an oncogene in gastri | |||
T14904 | CCT244747 | Chk | Cell Cycle/Checkpoint |
CCT244747 is a CHK1 inhibitor (IC50: 7.7 nM) and also abrogates G2 checkpoint (IC50: 29 nM). | |||
T62775 |
CCT245232
|
||
CCT245232 是一种有效的热激因子 1 (HSF1) 抑制剂。其中 HSF1 是一种热激反应的主要调节因子,能够诱导多个基因以响应温度升高和其他压力。CCT245232 具有潜力进行增殖性疾病(如癌症)的研究。 | |||
T70553 |
CCT245737(S)
|
||
CCT245737(S) is a highly selective oral checkpoint kinase 1 (CHK1) inhibitor. | |||
T10718 |
CCT241533
|
Chk | Cell Cycle/Checkpoint |
CCT241533 is an effective and selective ATP competitive inhibitor of CHK2 (Ki: 1.16 nM; IC50: 3 nM). |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-02183 |
CCT2 Protein, Human, Recombinant (His & SUMO)
CCT2,99D8.1,CCT-beta,TCP-1-beta,<... |
Human | E. coli |
Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. The TRiC complex plays a role in the folding of actin and tubulin. CCT2 Protein, Human, Recombinant (His & S... |